國家衛生研究院 NHRI:Item 3990099045/11413
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 858839      線上人數 : 817
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11413


    題名: Effects of statin use in advanced chronic kidney disease patients
    作者: Huang, TM;Wu, VC;Lin, YF;Wang, JJ;Shiao, CC;Chen, L;Chueh, SJ;Chueh, E;Yang, SY;Lai, TS;Lin, SL;Chu, TS;Wu, KD;National Taiwan University Hospital Study Group on Acute Renal Failure
    貢獻者: Institute of Population Health Sciences
    摘要: Although statin treatment is recommended for patients with chronic kidney disease (CKD) stages I(-)IV, its potential benefits have not been reported in advanced CKD patients. Non-diabetic patients with advanced CKD (pre-dialysis patients, estimated glomerular filtration rate <15 mL/min/1.73 m(2)) were enrolled from a National Health Insurance Research Database with a population of 23 million. Statin users and non-users were matched using propensity scoring and analyzed using Cox proportional hazards models, taking mortality as a competing risk with subsequent end-stage renal disease (ESRD) and statin doses as time-dependent variables. A total of 2551 statin users and 7653 matched statin non-users were identified from a total 14,452 patients with advanced CKD. Taking mortality as a competing risk, statin use did not increase the risk of new-onset diabetes mellitus (NODM) or decrease the risk of de novo major adverse cardiovascular events (MACE), but reduced all-cause mortality (hazard ratio (HR) = 0.59 [95% CI 0.42(-)0.84], p = 0.004) and sepsis-related mortality (HR = 0.53 [95% CI 0.32(-)0.87], p = 0.012). For advanced CKD patients, statin was neither associated with increased risks of developing NODM, nor with decreased risk of de novo MACE occurrence, but with a reduced risk of all-cause mortality, mainly septic deaths.
    日期: 2018-09-17
    關聯: Journal of Clinical Medicine. 2018 Sep 17;7(9):Article number 285.
    Link to: http://dx.doi.org/10.3390/jcm7090285
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2077-0383&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000445635800059
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85114272652
    顯示於類別:[陳麗光] 期刊論文

    文件中的檔案:

    檔案 大小格式瀏覽次數
    PUB30227675.pdf958KbAdobe PDF387檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋